Concepedia

Dodheri S. Samiulla

DS

Statistics

Publications

9

Citations

193

H-Index

9

Active since

2005

Affiliations

Aurigene Discovery Technologies (India)(Current)

Curis (United States)

Loyola University Medical Center

Providence College

Harvard University Press

Dodheri S. Samiulla is an author at Aurigene Discovery Technologies (India) specializing in pharmacology, tumor immunology, and medicinal chemistry.

Publications per year

2005–2020

9

Publications

9

Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies

Venkateshwar Rao Gummadi, Anima Boruah, Bharathi Raja Ainan et al. · ACS Medicinal Chemistry Letters · 2020 · 59 citations · Full text

, , +17

Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors

Rajeev Goswami, Subhendu Mukherjee, Gerd Wohlfahrt et al. · ACS Medicinal Chemistry Letters · 2013 · 28 citations · Full text

, , +17

Bioavailability of Eurycomanone in Its Pure Form and in a Standardised Eurycoma longifolia Water Extract

Norzahirah Ahmad, Dodheri S. Samiulla, Bee Ping Teh et al. · Pharmaceutics · 2018 · 23 citations · Full text

, , +17

A novel peptide therapeutic targeting PD1 immune checkpoint with equipotent antagonism of both ligands and a potential for better management of immune-related adverse events

Pottayil G. Sasikumar, Rajeev Shrimali, Sreenivas Adurthi et al. · Journal for ImmunoTherapy of Cancer · 2013 · 19 citations · Full text

, , +13

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

, , +17

1–5 of 9